Keel Point, LLC Seagen Inc. Transaction History

Keel Point, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$191.51 - $216.16 $3,638 - $4,107	19 Added 1.64%	1,175 $249,000
Q2 2023 Jul 12, 2023	BUY	$187.64 - $206.25 $4,878 - $5,362	26 Added 2.3%	1,156 $222,000
Q1 2023 Apr 03, 2023	BUY	$127.59 - $203.08 $144,176 - $229,480	1,130 New	1,130 $228,000
Q3 2022 Oct 05, 2022	SELL	$135.27 - $180.11 $167,193 - $222,615	-1,236 Closed	0 $0
Q2 2022 Aug 11, 2022	BUY	$108.81 - $179.33 $134,489 - $221,651	1,236 New	1,236 $217,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Keel Point, LLC, based on Form 13F filings with the SEC.

Stay updated on Keel Point, LLC with notifications on news.